Silica network improve the effect of fludarabine and paclitaxel on HCT8 cell line

Rom J Morphol Embryol. 2014;55(2 Suppl):545-51.

Abstract

This paper reports the potential of silica network to sensitize tumor cells and stimulate antitumor toxicity of fludarabine (FLU) and paclitaxel (PAC) against HCT8 cells. SiO₂, SiO₂/FLU and SiO₂/PAC nanostructured materials were characterized by X-Ray Diffraction, Scanning Electron Microscopy, InfraRed Microscopy and in vitro biological assays. When using SiO₂/PAC, it can be observed that the cytostatic effect of PAC is boosted only at high concentrations of this material. On the other hand, in the case of SiO₂/FLU, data showed an enhancement in the cytostatic activity of FLU by up to 25%, also when using this nanomaterial in low doses. These data represent preliminary study on the impact on silica nano-networks in targeted delivery and controlled release of antitumor drugs and they may be efficiently used for future biomedical applications in cancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials / pharmacology
  • Cell Shape / drug effects
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Humans
  • Microscopy, Electron, Scanning
  • Paclitaxel / pharmacology*
  • Silicon Dioxide / chemistry*
  • Spectrophotometry, Infrared
  • Tumor Cells, Cultured
  • Vidarabine / analogs & derivatives*
  • Vidarabine / pharmacology
  • X-Ray Diffraction

Substances

  • Biocompatible Materials
  • Silicon Dioxide
  • Vidarabine
  • fludarabine
  • Paclitaxel